PROTÉINES DE LIAISON BISPÉCIFIQUES DE TYPE ANTICORPS SE LIANT SPÉCIFIQUEMENT À CD3 ET CD123

The present invention concerns antibody-like binding protein specifically binding to CD3 and CD123. The invention also relates to pharmaceutical compositions comprising said antibody-like binding protein and the use of said pharmaceutical compositions and antibody-like binding protein to treat cance...

Full description

Saved in:
Bibliographic Details
Main Authors LANGE, Christian, SCHNEIDER, Marion, WONEROW, Peter, BEIL, Christian, ALBRECHT, Jana, RAO, Ercole, BENINGA, Jochen, GUERIF, Stéphane, KROLL, Katja, LEUSCHNER, Wulf Dirk
Format Patent
LanguageFrench
Published 22.05.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns antibody-like binding protein specifically binding to CD3 and CD123. The invention also relates to pharmaceutical compositions comprising said antibody-like binding protein and the use of said pharmaceutical compositions and antibody-like binding protein to treat cancer. The invention further relates to isolated nucleic acids, vectors and host cells comprising a sequence encoding said antibody-like binding protein.
Bibliography:Application Number: MA20170045680